The article below, co-authored by Mark Reisenauer, president of Astellas Pharma US, Tim Walbert, chairman, president and CEO of Horizon Therapeutics, and Peter Anastasiou, executive vice president...

Astellas was recently ranked in Seramount’s (formerly Working Mother Media) 2021 100 Best Companies and Best Companies for Dads lists. We recognize Carrie Schimizzi, Executive Director,...

Astellas is committed to partnering with national and local non-profit organizations to help improve access to healthcare for underserved groups in the United States. In Fiscal Year 2020, the...

Improved score marks continuing effort in growing inclusive culture to support people with disabilities For the second year in a row, Astellas has been included in the Disability Equality Index as...

Astellas, through its Mitobridge affiliate, has dosed the first patient in its pivotal Phase 2/3 clinical trial for ASP0367*, an oral investigational drug that may improve exercise intolerance and...

Astellas Pharma Inc. announced changes in its Global Commercial Leadership Team reporting to Chief Commercial Officer Yukio Matsui aligned with the focuses for the new Corporate Strategic Plan 2021 (CSP2021).

Astellas is at an inflection point in our evolution, facing opportunities presented by our growing pipeline, but amidst a rapidly changing environment that is transforming the ways every segment...

To further our mission to meet patients’ unmet medical needs through innovative pharmaceutical products, we recently announced several strategic executive promotions in the Quality Assurance...

As part of our ranking among Working Mother Magazine’s Top 10 companies and among the top 30 for working dads, we selected Dominique Talbert, director Scientific Publications, Medical &...

By Yoshitsugu Shitaka, President, Astellas Institute for Regenerative Medicine Astellas strives to be on the forefront of healthcare change and our work in regenerative medicine is a clear example...